Effectiveness of homologous/heterologous booster COVID-19 vaccination schedules against severe illness in general population and clinical subgroups in three European countries

Background rates of 41 adverse events of special interest for COVID-19 vaccines in 10 European healthcare databases – an ACCESS cohort study

Safety of COVID-19 Vaccines Among the Paediatric Population: Analysis of the European Surveillance Systems and Pivotal Clinical Trials “

Cohort Event Monitoring of Adverse Reactions to COVID-19 Vaccines in Seven European Countries: Pooled Results on First Dose.

Myocarditis and pericarditis associated with SARS-CoV-2 vaccines: A population-based descriptive cohort and a nested self-controlled risk interval study using electronic health care data from four European countries

Incidence of severe and non-severe SARS-CoV-2 infections in children and adolescents: a population-based cohort study using six healthcare databases from Italy, Spain, and Norway

Safety of COVID-19 Vaccines among People with History of Allergy: A European Active Surveillance Study

Applying two approaches to detect unmeasured confounding due to time-varying variables in a self-controlled risk interval design evaluating COVID-19 vaccine safety signals, using myocarditis as a case example

What is the safety of COVID-19 vaccines in immunocompromised patients? Results from the European “Covid Vaccine Monitor” active surveillance study

A comparison of four self-controlled study designs in an analysis of COVID-19 vaccines and myocarditis using five European databases